Search

everythinglearnresearchcommunity

for

Search:↓

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

Genomic approach finds new possible treatments for hair loss.

Low levels of certain trace elements might contribute to hair loss in Egyptian women.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Certain mutations in a hair growth-related gene cause a type of genetic hair loss.

Gentle hair care and avoiding harsh treatments can help manage hair loss.

Certain growth factors significantly affect hair loss in women with telogen effluvium.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

The Hair India 2010 conference introduced a new hair loss classification and highlighted advanced diagnostic techniques in trichology.

Androgenetic alopecia is complex and needs more research for better treatments.

The hair follicle infundibulum plays a key role in skin health and disease, and understanding it better could lead to new skin disease treatments.

Polarized dermoscopy is slightly better than nonpolarized for diagnosing hair disorders, with each method having its own strengths.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Androgenetic alopecia may be irreversible due to the detachment of a muscle from hair follicles.

Stem cell therapies show promise for hair regrowth but face production and application challenges.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

CD25+ CD4+ Tregs and certain plasma proteins are linked to hair loss.

Certain genes and X chromosome patterns may significantly contribute to the development of hair loss.

Androgenic alopecia causes hair thinning, and treatments include minoxidil, finasteride, and light therapy.

Activating mitophagy may help manage a key immune response involved in the hair loss condition alopecia areata.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Giant cells found in some male pattern baldness cases may help diagnose it and suggest hair is mistakenly seen as foreign by the body.

COVID-19 infection may trigger alopecia areata in some patients.

The study suggests that changes in immune system receptors and their interaction with a cell component may be important in the development of a type of hair loss condition.

A specific pathway involving AR, miR-221, and IGF-1 plays a key role in causing common hair loss.

Men with high genetic risk for Polycystic Ovary Syndrome (PCOS) have increased chances of obesity, type 2 diabetes, heart disease, and hair loss, showing PCOS risk factors can affect both genders.